Join Us: On-demand GLUT3 expression augments CAR-T cell metabolic fitness and antitumor efficacy in glioblastoma models
We are thrilled to announce that the Japan Association of Cancer Immunology (JACI), in affiliation with the World Immunotherapy Council (WIC), is co-organizing the upcoming WIC APAC Regional Webinar this August!
As we delve deeper into next-generation cellular therapies, overcoming the metabolic challenges of treating solid tumors remains a critical milestone. We are honored to host Dr. Keisuke Watanabe, MD, PhD, Senior Staff Scientist from the National Cancer Center Japan, who will present his groundbreaking research on how on-demand GLUT3 expression can significantly boost CAR-T cell metabolic fitness and antitumor efficacy in glioblastoma models.
💡 Why You Can’t Miss This Session:
This exclusive webinar is tailored for researchers, clinicians, and students eager to discover pioneering approaches in neuro-oncology and immunotherapy. By joining us, you will:
Explore Metabolic Fitness: Understand the role of GLUT3 expression in enhancing the survival and function of CAR-T cells within hostile tumor microenvironments.
Breakthroughs in Glioblastoma: Gain insights into novel therapeutic strategies for tackling one of the most challenging solid tumors.
Connect with APAC Leaders: Engage with top-tier experts from Japan and Singapore driving the future of cancer immunotherapy.
Event Details At a Glance:
Topic: On-demand GLUT3 expression augments CAR-T cell metabolic fitness and antitumor efficacy in glioblastoma models
Date: Friday, 21 August 2026
Time: 12:00 PM (UTC+8, Singapore) / 1:00 PM (UTC+9, Japan)
Speaker: Dr. Keisuke Watanabe, MD, PhD (National Cancer Center Japan)
Moderators:
Dr. Joe Yeong, MD, PhD
Prof. Hiroaki Ikeda, MD, PhD (Nagasaki University Graduate School of Biomedical Sciences)
Admission: Complimentary (Pre-Registration Required)